These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38707832)

  • 1. A Prospective Study of the Association Between Plasma Calprotectin Levels and New-Onset CKD in the General Population.
    Bourgonje AR; Bourgonje MF; la Bastide-van Gemert S; Nilsen T; Hidden C; Gansevoort RT; Mulder DJ; Hillebrands JL; Bakker SJL; Dullaart RPF; van Goor H; Abdulle AE
    Kidney Int Rep; 2024 May; 9(5):1265-1275. PubMed ID: 38707832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Neutrophil Gelatinase-Associated Lipocalin Associates with New-Onset Chronic Kidney Disease in the General Population.
    Bourgonje AR; Abdulle AE; Bourgonje MF; Kieneker LM; la Bastide-van Gemert S; Gordijn SJ; Hidden C; Nilsen T; Gansevoort RT; Mulder DJ; Dullaart RPF; de Borst MH; Bakker SJL; van Goor H
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
    De Jong MA; Eisenga MF; van Ballegooijen AJ; Beulens JWJ; Vervloet MG; Navis G; Gansevoort RT; Bakker SJL; De Borst MH
    Nephrol Dial Transplant; 2021 Jan; 36(1):121-128. PubMed ID: 32124925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum free sulfhydryl status associates with new-onset chronic kidney disease in the general population.
    Bourgonje AR; Abdulle AE; Bourgonje MF; Binnenmars SH; Gordijn SJ; Bulthuis MLC; la Bastide-van Gemert S; Kieneker LM; Gansevoort RT; Bakker SJL; Mulder DJ; Pasch A; de Borst MH; van Goor H
    Redox Biol; 2021 Dec; 48():102211. PubMed ID: 34896941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Calprotectin Levels Associate With New-Onset Hypertension in the General Population: A Prospective Cohort Study.
    Bourgonje AR; Bourgonje MF; la Bastide-van Gemert S; Nilsen T; Hidden C; Gansevoort RT; Bakker SJL; Mulder DJ; Dullaart RPF; Abdulle AE; van Goor H
    J Am Heart Assoc; 2024 Jan; 13(1):e031458. PubMed ID: 38156449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Calprotectin and New-onset Type 2 Diabetes in the General Population: A Prospective Cohort Study.
    Bourgonje AR; Bourgonje MF; Sokooti S; la Bastide-van Gemert S; Nilsen T; Hidden C; Gansevoort RT; Mulder DJ; Hillebrands JL; Bakker SJL; van Beek AP; Dullaart RPF; van Goor H; Abdulle AE
    J Clin Endocrinol Metab; 2024 Dec; 110(1):e150-e159. PubMed ID: 38436468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging plasma biomarker Dickkopf-3 (DKK3) and its association with renal and cardiovascular disease in the general population.
    Piek A; Smit L; Suthahar N; Bakker SJL; de Boer RA; Silljé HHW
    Sci Rep; 2021 Apr; 11(1):8642. PubMed ID: 33883651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Homocysteine Is a Predictive Factor for Accelerated Renal Function Decline and Chronic Kidney Disease in a Community-Dwelling Population.
    Xiao W; Ye P; Wang F; Cao R; Bai Y; Wang X
    Kidney Blood Press Res; 2021; 46(5):541-549. PubMed ID: 34365457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Calprotectin Levels Associate with Suspected Metabolic-Associated Fatty Liver Disease and All-Cause Mortality in the General Population.
    Bourgonje AR; van den Berg EH; Kieneker LM; Nilsen T; Hidden C; Bakker SJL; Blokzijl H; Dullaart RPF; van Goor H; Abdulle AE
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.
    Keyzer CA; Lambers-Heerspink HJ; Joosten MM; Deetman PE; Gansevoort RT; Navis G; Kema IP; de Zeeuw D; Bakker SJ; de Borst MH;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2119-27. PubMed ID: 26450935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome?
    van der Velde M; Bello AK; Brantsma AH; El Nahas M; Bakker SJ; de Jong PE; Gansevoort RT
    Nephrol Dial Transplant; 2012 Jun; 27(6):2275-83. PubMed ID: 22231032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the Urine-to-Plasma Urea Ratio With CKD Progression.
    Liu J; Bankir L; Verma A; Waikar SS; Palsson R
    Am J Kidney Dis; 2023 Apr; 81(4):394-405. PubMed ID: 36356680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary albumin excretion and cancer risk: the PREVEND cohort study.
    Luo L; Kieneker LM; van der Vegt B; Bakker SJL; Gruppen EG; Casteleijn NF; de Boer RA; Suthahar N; de Bock GH; Aboumsallem JP; Vart P; Gansevoort RT
    Nephrol Dial Transplant; 2023 Nov; 38(12):2723-2732. PubMed ID: 37226556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin B6, Inflammation, and Cardiovascular Outcome in a Population-Based Cohort: The Prevention of Renal and Vascular End-Stage Disease (PREVEND) Study.
    Minović I; Kieneker LM; Gansevoort RT; Eggersdorfer M; Touw DJ; Voerman AJ; Connelly MA; Boer RA; Hak E; Bos J; Dullaart RPF; Kema IP; Bakker SJL
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32899820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low potassium excretion but not high sodium excretion is associated with increased risk of developing chronic kidney disease.
    Kieneker LM; Bakker SJ; de Boer RA; Navis GJ; Gansevoort RT; Joosten MM
    Kidney Int; 2016 Oct; 90(4):888-96. PubMed ID: 27575557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population.
    Kieneker LM; Eisenga MF; Joosten MM; de Boer RA; Gansevoort RT; Kootstra-Ros JE; Navis G; Bakker SJ
    PLoS One; 2017; 12(3):e0174686. PubMed ID: 28346526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Educational level and risk of chronic kidney disease: longitudinal data from the PREVEND study.
    Thio CHL; Vart P; Kieneker LM; Snieder H; Gansevoort RT; Bültmann U
    Nephrol Dial Transplant; 2020 Jul; 35(7):1211-1218. PubMed ID: 30541108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between C-reactive protein levels and the risk for chronic kidney disease hospitalizations in adults of a remote Indigenous Australian community - A prospective cohort study.
    Arnold LW; Hoy WE; Wang Z
    Nephrology (Carlton); 2017 Sep; 22(9):699-705. PubMed ID: 27312245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of epidermal growth factor and rapid loss of kidney function.
    Norvik JV; Harskamp LR; Nair V; Shedden K; Solbu MD; Eriksen BO; Kretzler M; Gansevoort RT; Ju W; Melsom T
    Nephrol Dial Transplant; 2021 Sep; 36(10):1882-1892. PubMed ID: 33068410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.